 |
Dr. Jallal Gnaim
, the entrepreneur of CapsuTech, is an experienced pharmaceutical chemist with
vast experience in development of new formulations for pharmaceutical and
cosmetic usage. Dr. Gnaim has both academic as well as industrial experience in
leading companies. He served as a Senior Research Team Head in leading cosmetic
and chemical companies and at present he is an active academic researcher.
Dr. Ben-Tsion Williger , the CEO of CapsuTech, comes from the
fields of cancer research and has a firm scientific experience. Dr. Williger
served in several biotechnology companies as a Research Team Head, Department
Head and CEO of CancerTek Pharmaceuticals. In his last position as the CEO of
BWP Dr. Williger provided technological and business development support to
early stage biotechnology and medical device companies.
Dr. Michael Peled,
Dr. Peled is a highly experienced scientist with a robust grasp of industrial chemistry. Dr. Peled accomplished his Ph.D. at the Department of Organic Chemistry, the Technion- Institute of Technology, Haifa. Later, Dr. Peled held a Research Associate position at the University of California, Department of Chemistry, Berkley, California. Upon returning to Israel joined Dr. Peled Bromine Compounds Ltd and currently serves as the Organic and Plastics Manager. In parallel to his work, Dr. Peled also accomplished his MBA studies at the Ben-Gurion University of the Negev. Dr. Peled brings with him to CapsuTech unique applicative technical and business perspective.
Mr. Tamim Yasin, Mr. Yasin is one of the founders and investors of NGT and serves as NGT’s Chairman of Board. Mr. Yasin, a leading entrepreneur in the Arab sector in Israel, is the owner of "Obec Gas", a leading gas company dominating 50% of the Arab market. Mr. Yasin is also involved in several Israeli and Palestinians businesses. Mr. Yasin is also Member of Board Directors of the Center for Jewish-Arab Economic Development, as well as of the Arab Business Club.
|
|
|
